Appendix 2.
Reviewer disclosure of relationships with industry and other entities
| Peer Reviewer | Employment | Honoraria/ speaking/ consulting |
Speakers' bureau | Research* | Fellowship support* | Ownership/ partnership/ principal/ majority stockholder |
Stock or stock options | Intellectual property/ royalties |
Other |
|---|---|---|---|---|---|---|---|---|---|
| Elizabeth Davenport, MSN, CNML | Sanger Heart & Vascular Institute - Atrium Health, Charlotte, North Carolina | 1: Biotronik 1: Boston Scientific 1: Rhythm Management Group Corp |
None | None | None | None | None | None | None |
| Vicki Freedenberg, PhD, RN, MSN | Children's National Hospital, Washington, DC | None | None | None | None | None | None | None | None |
| Taya V. Glotzer, MD | Hackensack University Medical Center, Hackensack, New Jersey | 1: Abbott 1: Mayo Clinic 1: Medtronic |
None | None | None | None | None | None | None |
| Jin-Long Huang, MD, PhD | Taichung Veterans General Hospital, Taichung City, Taiwan | None | None | None | None | None | None | None | None |
| Takanori Ikeda, MD, PhD, FACC, FESC, FJCS | Toho University Faculty of Medicine/ Medical Center, Tokyo, Japan | None | None | None | None | None | None | None | None |
| Daniel B. Kramer, MD, FACC | Beth Israel Deaconess Medical Center, Boston, Massachusetts | 1: Firefly Health 1: HeartCoR, LLC |
None | 0: Greenwall Foundation 0: NIH |
None | None | None | None | None |
| David Lin, MD, FHRS, FACC | Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania | 1: Abbott 1: BioTelemetry 1: Philips |
None | None | None | None | None | None | None |
| Ulises Rojel-Martínez, MD, FHRS | South Medical Center, Puebla, México | None | None | None | None | None | None | None | None |
| Markus Stühlinger, MD, FACC, FEHRA | Medical University of Innsbruck, Innsbruck, Austria | 1: Biotronik 1: Daiichi Sankyo 1: Medtronic |
None | None | None | None | None | None | None |
| Paul D. Varosy, MD | VA Eastern Colorado Health Care System, Aurora, Colorado | None | None | 4: NIH | None | None | 2: HRCRS/ 3PH Alliance | None | 0: ACC 0: NCDR |
Number value: 0 = $0; 1 = ≤ $10,000; 2 = > $10,000 to ≤ $25,000; 3 = > $25,000 to ≤ $50,000; 4 = > $50,000 to ≤ $100,000; 5 = > $100,000.
This table is a comprehensive list of the relationships with industry and other entities (RWI)―regardless of relevance to the document topic―disclosed by the reviewers at the time the document was under review. The table does not necessarily reflect the RWI of the reviewers at the time of publication. Please refer to the HRS Code of Ethics and Professionalism for definitions of disclosure categories or additional information about the HRS policy on the disclosure of relationships with industry and other entities. *Research and fellowship support are classed as programmatic support. Sources of programmatic support are disclosed but are not regarded as a relevant relationship with industry for writing group members or reviewers.
ACC = American College of Cardiology; HRCRS = Heart Rhythm Clinical Research Solutions; NCRD = National Cardiovascular Data Registry; NIH = National Institutes of Health.